CAC Software vs ClearRead CT
AI Verdict
Choose CAC Software if…
Choose Imbio's CAC Software if your primary need is a highly specialized and detailed quantification of coronary artery calcification from non-contrast chest CTs. This tool is ideal for cardiologists and radiologists seeking comprehensive metrics like Agatston score, arterial age, and calcified lesion mass/volume, along with 3D visualizations, to precisely assess cardiovascular risk.
View CAC Software →Choose ClearRead CT if…
Choose ClearRead CT if your clinical workflow requires a versatile AI suite that excels in both coronary artery calcification analysis and advanced pulmonary nodule detection. This tool is particularly beneficial for radiologists and pulmonologists aiming to improve diagnostic accuracy, reduce reading times, and streamline the interpretation of cardiothoracic CTs by leveraging features like patented vessel suppression and automated nodule tracking.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC Software | ClearRead CT |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based (SaaS), integrates with PACS | On-premise (stand-alone server, virtual machine) and Cloud |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTBoth tools integrate into existing DICOM/PACS workflows. However, ClearRead CT explicitly highlights 'Reduced Reading Time (up to 36%)' and 'Seamless PACS Integration / Vendor-neutral processing' as key features, directly indicating a strong focus on improving workflow efficiency and user experience.
Clinical Value
ClearRead CTWhile both offer Coronary Artery Calcification (CAC) scoring, ClearRead CT provides broader clinical value by also offering comprehensive pulmonary nodule detection, characterization, and automated tracking. It also claims 'Improved Detection Accuracy (29% reduction in missed actionable nodules)' for nodules, addressing a critical need in oncology.
Pricing & Value
TieBoth CAC Software and ClearRead CT state 'contact for pricing' and do not provide any specific pricing details or transparent value-based pricing information in the provided facts or publicly available web searches. Therefore, it is not possible to distinguish between them on this dimension.
Enterprise Readiness
CAC SoftwareTool A (CAC Software) explicitly states 'has_baa': '1' and 'hipaa_compliant': '1', along with FDA clearance and flexible deployment options (Cloud, On-premise, Partner platforms). Tool B (ClearRead CT) states 'likely, contact vendor for details' for BAA and HIPAA, making Tool A's explicit claims a stronger indicator of enterprise readiness.
Innovation
ClearRead CTBoth tools leverage AI/deep learning. However, ClearRead CT highlights 'Patented Vessel Suppression (Clear Visual Intelligence)' as a key feature, which is a distinct and innovative technology designed to enhance diagnostic clarity by removing obscuring vessels, giving it an edge in innovation.
Support & Docs
ClearRead CTRiverain Technologies (Tool B) provides a dedicated 'Support' section on its website with clear contact information, FAQs, system requirements, workflows, and accessible manuals and documentation. They also offer 'Customer Success Live Sessions' and emphasize seamless support. Imbio (Tool A) also offers phone and email support and mentions support documents, but Riverain's public resources appear more comprehensive and readily available.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC Software | ClearRead CT |
|---|---|---|
| Company | 4DMedical (Imbio CAC Software) | RIVERAIN TECHNOLOGIES |
| Description | Imbio's Coronary Artery Calcification (CAC) software is a set of automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). | ClearRead CT is an FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology. |
| Key Features | Automated image post-processing for coronary artery calcification, Quantification of calcification within coronary arteries, Outputs Agatston score, arterial age, calcified lesion mass and volume, Provides 3D visualizations and annotated images, Non-invasive analysis from non-contrast chest CT scans, Integrates into existing DICOM viewing workflow, Supports risk assessment for coronary artery disease, Deep-learning based analysis | Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement (volume, diameter, location, type, depth), Automated Nodule Tracking and Comparison to Prior Exams, Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs), Reduced Reading Time (up to 36%), Improved Detection Accuracy (29% reduction in missed actionable nodules), Seamless PACS Integration / Vendor-neutral processing |
| Data Export | DICOM files and summary PDF reports | Not specified |
| Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CAC Software and ClearRead CT.